Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


Articles published in Biochem Biophys Res Commun

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    May 2024
  1. ZHANG S, Lou S, Bian W, Liu J, et al
    Selective eradication of venetoclax-resistant monocytic acute myeloid leukemia with iron oxide nanozymes.
    Biochem Biophys Res Commun. 2024;719:150117.
    PubMed     Abstract available


    January 2024
  2. SUZUKI S, Liu J, Sato Y, Miyake R, et al
    Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells.
    Biochem Biophys Res Commun. 2024;710:149541.
    PubMed     Abstract available


    November 2023
  3. LYSIKOVA DV, Vasileva VY, Chubinskiy-Nadezhdin VI, Morachevskaya EA, et al
    Capsazepine activates amiloride-insensitive ENaC-like channels in human leukemia cells.
    Biochem Biophys Res Commun. 2023;687:149187.
    PubMed     Abstract available


    October 2023
  4. NIU F, Yang R, Feng H, Liu Y, et al
    A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction.
    Biochem Biophys Res Commun. 2023;684:149125.
    PubMed     Abstract available


  5. XUE J, Chu P, Gao W, Wang F, et al
    XPO1 is a new target of homoharringtonine (HHT): Making NPMc(+) AML cells much more sensitive to HHT treatment.
    Biochem Biophys Res Commun. 2023;675:155-161.
    PubMed     Abstract available


    September 2023
  6. DENG Y, Cheng Q, He J
    HDAC inhibitors: Promising agents for leukemia treatment.
    Biochem Biophys Res Commun. 2023;680:61-72.
    PubMed     Abstract available


    June 2023
  7. LI C, Wang Z, Wei B, Liu Z, et al
    Upregulation of ROBO3 promotes proliferation, migration and adhesion of AML cells and affects the survival of AML patients.
    Biochem Biophys Res Commun. 2023;661:1-9.
    PubMed     Abstract available


    May 2023
  8. SAKURADA-AONO M, Sakamoto T, Kobayashi M, Takiuchi Y, et al
    HTLV-1 bZIP factor impairs DNA mismatch repair system.
    Biochem Biophys Res Commun. 2023;657:43-49.
    PubMed     Abstract available


    April 2023
  9. ZHU Y, Zhao Z, Xue M, Wang D, et al
    Ciclopirox olamine sensitizes leukemia cells to natural killer cell-mediated cytolysis by upregulating NKG2DLs via the Akt signaling pathway.
    Biochem Biophys Res Commun. 2023;659:10-19.
    PubMed     Abstract available


    February 2023
  10. TANG J, Zhong J, Yang Z, Su Q, et al
    Glyoxalase 1 inhibitor BBGC suppresses the progression of chronic lymphocytic leukemia and promotes the efficacy of Palbociclib.
    Biochem Biophys Res Commun. 2023;650:96-102.
    PubMed     Abstract available


    November 2022
  11. XU Y, Li J, Luo Y, Ma J, et al
    Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting beta-ARs signaling pathway.
    Biochem Biophys Res Commun. 2022;639:150-160.
    PubMed     Abstract available


  12. VERMA MK, Samant C, Kale R, Patra S, et al
    Dual PI3Kdeltagamma inhibition demonstrates potent anticancer effects in diffuse large B-cell lymphoma models: Discovery and preclinical characterization of LL-00084282.
    Biochem Biophys Res Commun. 2022;637:267-275.
    PubMed     Abstract available


    September 2022
  13. FENG H, Liu Y, Zhang M, Liu R, et al
    De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy.
    Biochem Biophys Res Commun. 2022;629:152-158.
    PubMed     Abstract available


    August 2022
  14. HAO C, Shao X, Song J, Peng M, et al
    Corrigendum to "SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia".
    Biochem Biophys Res Commun. 2022 Aug 8. pii: S0006-291X(22)01059.
    PubMed    


  15. YANG Y, Liu L, Tucker HO
    Induction of chronic lymphocytic leukemia-like disease in STYK1/NOK transgenic mice.
    Biochem Biophys Res Commun. 2022;626:51-57.
    PubMed     Abstract available


    July 2022
  16. WU J, Zhang Y, Li X, Ren J, et al
    Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.
    Biochem Biophys Res Commun. 2022;622:149-156.
    PubMed     Abstract available


    June 2022
  17. PHAM LT, Peng H, Ueno M, Kohno S, et al
    RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia.
    Biochem Biophys Res Commun. 2022;621:74-79.
    PubMed     Abstract available


  18. LIU Z, Zhong L, Dan W, Chu X, et al
    miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting Axin2 and modulating the Wnt/beta-catenin pathway.
    Biochem Biophys Res Commun. 2022;620:83-91.
    PubMed     Abstract available


  19. HAO S, Yang C, Song P, Shi H, et al
    CLDN4 promotes growth of acute myeloid leukemia cells via regulating AKT and ERK1/2 signaling.
    Biochem Biophys Res Commun. 2022;619:137-143.
    PubMed     Abstract available


    May 2022
  20. LIU L, Liu B, Guan G, Kang R, et al
    Cyclophosphamide-induced GPX4 degradation triggers parthanatos by activating AIFM1.
    Biochem Biophys Res Commun. 2022;606:68-74.
    PubMed     Abstract available


    April 2022
  21. KUTTIKRISHNAN S, Bhat AA, Mateo JM, Ahmad F, et al
    Anticancer activity of Neosetophomone B by targeting AKT/SKP2/MTH1 axis in leukemic cells.
    Biochem Biophys Res Commun. 2022;601:59-64.
    PubMed     Abstract available


    March 2022
  22. LI Y, Yuan S, Wu W, Zhou J, et al
    The hsa-miR-214-3p/ATGL axis regulates aberrant lipolysis to promote acute myeloid leukemia progression via PPARalpha in vitro.
    Biochem Biophys Res Commun. 2022;608:73-81.
    PubMed     Abstract available


  23. CHEN L, Fang W, Liu J, Qi X, et al
    Poricoic acid A (PAA) inhibits T-cell acute lymphoblastic leukemia through inducing autophagic cell death and ferroptosis.
    Biochem Biophys Res Commun. 2022;608:108-115.
    PubMed     Abstract available


  24. GIOVANNONI F, Vazquez CA, Thomas P, Gomez RM, et al
    Promyelocytic leukemia protein is a restriction factor for Junin virus independently of Z matrix protein.
    Biochem Biophys Res Commun. 2022;606:168-173.
    PubMed     Abstract available


  25. JAVIDAN M, Changaei M, Ramezani Tehrani F, Mosaffa N, et al
    Altered expression of leukemia inhibitory factor (LIF), LIFR, gp130, and IL11 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome.
    Biochem Biophys Res Commun. 2022;605:24-30.
    PubMed     Abstract available


    February 2022
  26. ISSAH MA, Wu D, Zhang F, Zheng W, et al
    Expression profiling of N(6)-methyladenosine modified circRNAs in acute myeloid leukemia.
    Biochem Biophys Res Commun. 2022;601:137-145.
    PubMed     Abstract available


  27. ZHOU J, Chen X, Zhou P, Sun X, et al
    Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia.
    Biochem Biophys Res Commun. 2022;600:29-34.
    PubMed     Abstract available


    January 2022
  28. HAO C, Shao X, Song J, Peng M, et al
    SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
    Biochem Biophys Res Commun. 2022;596:36-42.
    PubMed     Abstract available


    December 2021
  29. IMAYOSHI N, Yoshioka M, Tanaka K, Yang SM, et al
    CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.
    Biochem Biophys Res Commun. 2021;590:49-54.
    PubMed     Abstract available


  30. AMARI K, Sasagawa S, Imayoshi N, Toda Y, et al
    The CDK4/6-UCHL5-BRD4 axis confers resistance to BET inhibitors in MLL-rearranged leukemia cells by suppressing BRD4 protein degradation.
    Biochem Biophys Res Commun. 2021;588:147-153.
    PubMed     Abstract available


    November 2021
  31. OKAMOTO S, Miyano K, Kitakaze K, Kato H, et al
    Coculture in vitro with endothelial cells induces cytarabine resistance of acute myeloid leukemia cells in a VEGF-A/VEGFR-2 signaling-independent manner.
    Biochem Biophys Res Commun. 2021;587:78-84.
    PubMed     Abstract available


  32. LIAO F, Chen Y, Wu Q, Wen J, et al
    Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation.
    Biochem Biophys Res Commun. 2021;579:1-7.
    PubMed     Abstract available


    June 2021
  33. PENG H, Zou Y
    The leukocyte immunoglobulin-like receptor gp49B1, coexpressed with c-Kit, modulates hematopoiesis and B cell leukemia development.
    Biochem Biophys Res Commun. 2021;565:72-78.
    PubMed     Abstract available


    May 2021
  34. ZHU S, Liu J, Kang R, Yang M, et al
    Targeting NF-kappaB-dependent alkaliptosis for the treatment of venetoclax-resistant acute myeloid leukemia cells.
    Biochem Biophys Res Commun. 2021;562:55-61.
    PubMed     Abstract available


    April 2021
  35. ISHIURA M, Kitai Y, Kashiwakura JI, Muromoto R, et al
    Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival.
    Biochem Biophys Res Commun. 2021;556:185-191.
    PubMed     Abstract available


    January 2021
  36. AROLLA RG, Malladi S, Bhaduri U, Gayatri MB, et al
    Analysis of cellular models of clonal evolution reveals co-evolution of imatinib and HSP90 inhibitor resistances.
    Biochem Biophys Res Commun. 2021;534:461-467.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.